Grant: Foundation Grant
University of Toronto
$6,135,843.00
Human gene expression regulatory mechanisms
FY 2016-17
Summary
Most mutations in human DNA that cause disease are not in sequences that code for protein but rather in regulatory sequences that determine whether particular proteins, or parts of proteins, are made. These regulatory sequences are recognized by about 1600 regulatory proteins called transcription factors. We are studying a large family of more than 700 transcription factors known as the zinc finger proteins. We have unexpectedly discovered that the zinc finger proteins almost always recognize RNA as well as DNA and propose to identify the sequences that they recognize. This will enable better understanding of human disease and help us to better predict both what diseases might occur and how best to treat those diseases.
We are also studying several proteins in which mutations cause three devastating and fatal neurodegenerative diseases, spinal muscular atrophy, amyotrophic lateral sclerosis (ALS; also as known as Lou Gehrig's disease) and fronto-temporal dementia, as well as another protein important for the growth of many kinds of cancer cells. We propose to determine how the zinc finger proteins control the splicing together of RNA fragments to form contiguous segments that code for protein, as well as how the zinc finger proteins, the neurodegeneration proteins, and the cancer-promoting protein determine where RNA polymerase II, the enzyme that reads human genes, stops at the ends of genes. We will also try to identify chemicals that prevent RNA polymerase II from stopping and might be developed into new kinds of anti-cancer drugs.
Department
Program
Foundation Grant
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
354473
Name
Greenblatt Jack F
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Foundation Grant
Projecttitle
Human gene expression regulatory mechanisms
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$6,135,843
Cihrequipment2
$0
Programname2
Foundation Grant
Keyworddelim
Amyotrophic Lateral Sclerosis; Cancer; Chip Sequencing; Iclip Sequencing; Mass Spectrometry; Neurodegeneration; Rna Polymerase Ii; Splicing; Transcription; Transcription Termination
Abstract
Most mutations in human DNA that cause disease are not in sequences that code for protein but rather in regulatory sequences that determine whether particular proteins, or parts of proteins, are made. These regulatory sequences are recognized by about 1600 regulatory proteins called transcription factors. We are studying a large family of more than 700 transcription factors known as the zinc finger proteins. We have unexpectedly discovered that the zinc finger proteins almost always recognize RNA as well as DNA and propose to identify the sequences that they recognize. This will enable better understanding of human disease and help us to better predict both what diseases might occur and how best to treat those diseases.
We are also studying several proteins in which mutations cause three devastating and fatal neurodegenerative diseases, spinal muscular atrophy, amyotrophic lateral sclerosis (ALS; also as known as Lou Gehrig's disease) and fronto-temporal dementia, as well as another protein important for the growth of many kinds of cancer cells. We propose to determine how the zinc finger proteins control the splicing together of RNA fragments to form contiguous segments that code for protein, as well as how the zinc finger proteins, the neurodegeneration proteins, and the cancer-promoting protein determine where RNA polymerase II, the enzyme that reads human genes, stops at the ends of genes. We will also try to identify chemicals that prevent RNA polymerase II from stopping and might be developed into new kinds of anti-cancer drugs.
Competitiondate
201610
Approvedterm2
7 yrs 0 mth
Pinamesdelim
Greenblatt, Jack F
Approvedterm
7 ans 0 mois
Cihrcontribution2
~ $6,135,843~ $0~